Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
3.050
-0.010 (-0.33%)
At close: Mar 4, 2026, 4:00 PM EST
3.050
0.00 (0.00%)
After-hours: Mar 4, 2026, 4:10 PM EST
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $70.89 million as of March 4, 2026. Its market cap has decreased by -53.23% in one year.
Market Cap
70.89M
Enterprise Value
53.97M
1-Year Change
-53.23%
Ranking
Category
Stock Price
$3.05
Market Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has decreased from $152.13M to $70.89M, a decrease of -53.40%. That is a compound annual growth rate of -38.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 71.12M | -50.00% |
| Dec 31, 2025 | 142.25M | -8.50% |
| Dec 31, 2024 | 155.47M | 2.20% |
| Aug 13, 2024 | 152.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fractyl Health | 77.48M |
| Pliant Therapeutics | 76.81M |
| XBiotech | 71.34M |
| Adicet Bio | 70.95M |
| MediciNova | 69.40M |
| Annovis Bio | 68.38M |
| Q32 Bio | 68.32M |
| Cingulate | 65.74M |